DIVI - ETF AI Analysis

Top Page

Franklin LibertyQ International Equity Hedged ETF (DIVI)

Rating:66Neutral

Price Target:―

DIVI, the Franklin LibertyQ International Equity Hedged ETF, earns a solid overall rating driven mainly by high-quality global leaders like HSBC, AstraZeneca, Novartis, Toyota, and Rio Tinto, which show strong financial performance, positive earnings outlooks, and generally supportive technical trends. These strengths are slightly offset by holdings such as Roche and British American Tobacco, where valuation concerns, overbought signals, or earnings volatility introduce some caution. The main risk factor is the fund’s meaningful exposure to a few large international names and sectors like pharmaceuticals and financials, which can increase sensitivity to industry-specific or regional developments.

Positive Factors

Low Expense Ratio

The fund charges a relatively low fee, which helps investors keep more of their returns over time.

Strong Recent Performance

The ETF has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.

Global Diversification Outside the U.S.

Holdings spread across many developed markets like Japan, the UK, and Europe help reduce reliance on any single country’s economy.

Negative Factors

Heavy Financial Sector Exposure

With a large portion of assets in financial stocks, the fund is sensitive to downturns in banks and other financial companies.

Mixed Performance Among Top Holdings

While some major positions have performed strongly, others have been weak or lagging, which can create uneven results.

Limited U.S. Market Exposure

Because only a small slice of the portfolio is in U.S. stocks, investors who want significant exposure to the U.S. market may find this ETF less suitable.

DIVI vs. SPDR S&P 500 ETF (SPY)

AUM2.30B

RegionDeveloped Markets

Expense Ratio0.09%

Beta0.72

IssuerFranklin

Inception DateJun 01, 2016

Dividend Yield3.63%

Asset ClassEquity

Index TrackedMorningstar Developed Markets ex-North America Dividend Enhanced Select

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume345,567

30 Day Avg. Volume253,586

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

45.08

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering412

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DIVI Summary

Franklin LibertyQ International Equity Hedged ETF (DIVI) is an international stock fund that follows the Morningstar Developed Markets ex-North America Dividend Enhanced Select Index. It focuses on companies outside the U.S. that pay relatively high dividends, with major exposure to countries like Japan, the UK, and France. Well-known holdings include ASML, Nestlé, Toyota, and AstraZeneca. Investors might consider DIVI for income plus global diversification, while its currency hedging aims to reduce the impact of exchange rate swings. A key risk is that international stock prices can still rise and fall significantly with global markets.

How much will it cost me?The Franklin LibertyQ International Equity Hedged ETF (DIVI) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it is passively managed, focusing on tracking an index rather than active stock selection.

What would affect this ETF?The Franklin LibertyQ International Equity Hedged ETF (DIVI) could benefit from stable or growing dividend payouts in developed markets outside North America, particularly in sectors like financials and technology, which are its largest exposures. However, economic slowdowns or regulatory changes in these regions, as well as sector-specific challenges like reduced demand in industrials or healthcare, could negatively impact performance. Additionally, while currency hedging reduces volatility, unexpected shifts in global trade policies or geopolitical tensions might still affect the ETF's returns.

DIVI Top 10 Holdings

DIVI leans heavily on non-U.S. blue chips, with Europe and Japan doing most of the heavy lifting. ASML is the tech engine, rising and giving the fund a growth tilt on top of its dividend focus. Big pharma names like Roche, AstraZeneca, and Novartis are also climbing, helping health care act as a steady ballast. Financials such as HSBC and BNP Paribas are rising and add income punch, while Rio Tinto’s upswing in materials provides an extra boost. Overall, performance is broadly supported rather than dragged by any single laggard.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	2.45%	$55.92M	€438.37B	79.71%	76 Outperform
HSBA	HSBC Holdings	1.62%	$36.89M	£214.86B	45.65%	80 Outperform
NESN	Nestlé SA	1.47%	$33.49M	CHF202.47B	0.44%	71 Outperform
AZN	AstraZeneca	1.43%	$32.74M	$300.78B	22.44%	80 Outperform
ROG	Roche Holding AG	1.43%	$32.62M	CHF265.95B	26.90%	73 Outperform
NOVN	Novartis AG	1.29%	$29.41M	CHF238.47B	21.58%	80 Outperform
7203	Toyota Motor	1.25%	$28.44M	¥44.22T	23.81%	80 Outperform
RIO	Rio Tinto	1.05%	$24.01M	£113.05B	39.77%	82 Outperform
BATS	British American Tobacco	1.03%	$23.60M	£93.42B	35.76%	71 Outperform
BNP	BNP Paribas	1.02%	$23.21M	€94.26B	13.79%	77 Outperform

DIVI Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

41.00

Negative

100DMA

39.30

Positive

200DMA

37.34

Positive

Market Momentum

MACD

-0.03

Positive

RSI

34.84

Neutral

STOCH

24.46

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVI, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 42.21, equal to the 50-day MA of 41.00, and equal to the 200-day MA of 37.34, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 34.84 is Neutral, neither overbought nor oversold. The STOCH value of 24.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DIVI.

DIVI Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DIVI	―	―	$2.30B	0.09%	66 Neutral
IDV	―	―	$7.89B	0.50%	58 Neutral
HDEF	―	―	$2.27B	0.09%	68 Neutral
DTH	―	―	$632.22M	0.58%	62 Neutral
FIDI	―	―	$290.40M	0.18%	67 Neutral
EFAS	―	―	$42.98M	0.55%	55 Neutral

Performance Comparison

DIVI

Franklin LibertyQ International Equity Hedged ETF

40.31

8.72

27.60%

IDV

iShares International Select Dividend ETF

―

HDEF

Xtrackers MSCI EAFE High Dividend Yield Equity ETF

―

DTH

WisdomTree International High Dividend Fund

―

FIDI

Fidelity International High Dividend ETF

―

EFAS

Global X MSCI SuperDividend EAFE ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents